allied
academies
Virology Research Journal
Volume 1 Issue 4
Vaccines World 2017
Notes:
Page 51
November 09-10, 2017 Vienna, Austria
21
st
World Congress and Exhibition on
VACCINES, VACCINATION & IMMUNIZATION
Influence of genetically modified mosquitoes
in dengue epidemic network
Hafiz Abid Mahmood Malik
King Khalid University, Saudi Arabia
T
here are many examples of complex systems in the world
from different domains of life. For example, the social
contacts includes, the social networks of friendship, a covert
network of terrorists, sexual contact network, and scientific
collaboration network are all complex networks. Complex
networks play a significant role in the research of epidemic
diseases and in their modeling such as HIV/AIDS.The dengue
epidemic is a dynamic and complex phenomenon which
has gained much attention due to its harmful effects that
sometimes becomes a cause of death of a person. According to
WHO, it is estimated that approximately 3.6 billion people are
living in the dengue affected part of the world. It has become
an emerging challenge to health authorities and legislators,
as there are presently no authorized antibodies or particular
therapeutics for its treatment. The dengue fever is caused by
a mosquito of specific specie named as
Aedes aegypti.
It is
important to discuss here that only female
Aedes aegypti
is the
dengue vector that is also the super spreader of ZIKA virus.
The dataset (obtained fromMOH Selangor, Malaysia) showed
the results that proved the dengue epidemic as a scale-free
network (SFN) instead of random network. The scale-
free feature is very important in the treatment of epidemic
diseases. Here, we observe the influence of Genetically
Modified Mosquitoes (GMM) in a complex network of the
dengue epidemic. The results showed that GMM technique is
much suitable in SFN and can suppress the wild population
of
Aedes aegypti
. The results are important for the researchers
and policy makers who deal with the arbovirus epidemic
diseases like ZIKA virus.
hafiz.abid@live.iium.edu.myVirol Res J 2017, 1:4